Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01764659 · ClinicalTrials.gov registry record
4D-CT for Pancreatic Adenocarcinoma in Radiotherapy Simulation
A clinical trial, sponsored by University of Maryland, Baltimore.
- Completed
- Registry status
- 14
- Enrollment target
NCT01764659: Completed study, sponsored by University of Maryland, Baltimore.
NCT01764659 is a clinical trial that has completed, run by University of Maryland, Baltimore. The registered enrollment target is 14 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01764659 has completed, sponsored by University of Maryland, Baltimore.
- COMPLETED
- Registry status
- 14 participants
- Enrollment target
Study Summary
The primary objective is to study the feasibility and efficacy of individually optimized CE 4D-CT for PDA in radiotherapy simulation.
Primary Outcome
Image quality (anatomic details, motion artifacts, beam hardening and enhancement of pancreatic tissue and tumor were scored from 1 to 5, with 1 being very poor and 5 being excellent), CT number of pancreas and tumor, tumor-to-pancreas contrast, image noise and contrast-to-noise ration (CNR) were compared among contrast-enhanced (CE) 4DCT, CE 3DCT and 4DCT without contrast enhancement.
Interventions
- OTHER Contrast-enhanced 4D computed tomography
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 14 participants |
| Start Date | 2013-07 |
| Est. Completion | 2014-10 |
What the finished NCT01764659 record still lists
NCT01764659 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 14 participants, a relatively small participant target.
The record links to 0 conditions, and to 1 intervention - of which Contrast-enhanced 4D computed tomography is the first listed.
NCT01764659 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01764659 about?
NCT01764659 is a clinical study titled "4D-CT for Pancreatic Adenocarcinoma in Radiotherapy Simulation". The primary objective is to study the feasibility and efficacy of individually optimized CE 4D-CT for PDA in radiotherapy simulation.
What is the current status of trial NCT01764659?
This trial is currently completed. The enrollment target is 14 participants. The study started on 2013-07. Estimated completion is 2014-10.
What interventions are being tested in trial NCT01764659?
The interventions under investigation include: Contrast-enhanced 4D computed tomography (OTHER).
Who is sponsoring clinical trial NCT01764659?
This trial is sponsored by University of Maryland, Baltimore, which has 560 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02523092 · 14 participants · Phase 4
Use of CXCL9 as a Biomarker of Acthar Efficacy
- NCT04263285 · 14 participants · NA
Treatment of Depression Post-SCI
- NCT04743271 · 14 participants · NA
Food and Circadian Timing
- NCT05065671 · 14 participants · Phase 1
Microbiome Derived Metabolism and Pharmacokinetics
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia